These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 993657)

  • 1. Delayed hypersensitivity skin test in head and neck cancer.
    Kenefick TC
    J Laryngol Otol; 1976 Oct; 90(10):935-43. PubMed ID: 993657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
    Osoba D; Kersey PA; Clark RM; Rosen IB
    Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck.
    Lundy J; Wanebo H; Pinsky C; Strong E; Oettgen H
    Am J Surg; 1974 Oct; 128(4):530-3. PubMed ID: 4429642
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic abnormalities in head and neck cancer.
    Eilber FR; Morton DL; Ketcham AS
    Am J Surg; 1974 Oct; 128(4):534-8. PubMed ID: 4422512
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo anergy reversal with cimetidine in patients with cancer.
    Richtsmeier WJ; Eisele D
    Arch Otolaryngol Head Neck Surg; 1986 Oct; 112(10):1074-7. PubMed ID: 3755977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer.
    Flynn CJ; Khaouam N; Gardner S; Higgins K; Enepekides D; Balogh J; MacKenzie R; Singh S; Davidson J; Poon I
    Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):868-73. PubMed ID: 20650620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
    Torii C; Hida Y; Shindoh M; Akiyama K; Ohga N; Maishi N; Ohiro Y; Ono M; Totsuka Y; Kitagawa Y; Tei K; Sato Y; Hida K
    Anticancer Res; 2017 Mar; 37(3):1219-1225. PubMed ID: 28314285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of delayed cutaneous reactivity in head and neck cancer patients.
    Mandel MA; Kiehn CL
    Plast Reconstr Surg; 1974 Jan; 53(1):72-6. PubMed ID: 4588603
    [No Abstract]   [Full Text] [Related]  

  • 9. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunotherapy with B.C.G. for recurrent malignant melanoma.
    Gutterman JU; Mavligit G; McBride C; Frei E; Freireich EJ; Hersh EM
    Lancet; 1973 Jun; 1(7814):1208-12. PubMed ID: 4122562
    [No Abstract]   [Full Text] [Related]  

  • 11. Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases.
    Boysen ME; Zätterström UK; Evensen JF
    Anticancer Res; 2016 Jun; 36(6):2849-54. PubMed ID: 27272796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
    Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous reactivity in patients with cancer of the head and neck region.
    Mandel MA; Kiehn C
    Surg Forum; 1973; 24():534-5. PubMed ID: 4806088
    [No Abstract]   [Full Text] [Related]  

  • 14. [CEA studies in squamous cell carcinomas of the head and neck].
    Schröder M; Meyer T
    HNO; 1986 Aug; 34(8):334-42. PubMed ID: 3759515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The delayed hypersensitivity reaction in cancer patient: observations on sensitization by DNCB.
    Chakravorty RC; Curutchet HP; Coppolla FS; Park CM; Blaylock WK; Lawrence W
    Surgery; 1973 May; 73(5):730-5. PubMed ID: 4697093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumour recurrence in squamous head and neck cancer].
    Alvarez Marcos CA; Llorente Pendás JL; Franco Gutiérrez V; Fernández Espina H; Alonso Guervós M; Suárez Nieto C; Hermsen M
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):156-63. PubMed ID: 17428412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
    Newlands C; Currie R; Memon A; Whitaker S; Woolford T
    J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired immunologic reactivity and recurrence following cancer surgery.
    Eilber FR; Morton DL
    Cancer; 1970 Feb; 25(2):362-7. PubMed ID: 5413507
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor spread and reactivity to DNCB: (2, 4 Dinitro-1 chlorobenzene) skin test.
    el-Domeiri AA
    Int Surg; 1972 Aug; 57(8):617-9. PubMed ID: 5051760
    [No Abstract]   [Full Text] [Related]  

  • 20. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
    Maisel RH; Ogura JH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.